Dysregulation of trophoblast differentiation is implicated in the placental pathologies of intrauterine growth restriction and pre-eclampsia. P-glycoprotein (P-gp encoded by ABCB1) is an ATP-binding cassette transporter present in the syncytiotrophoblast layer of the placenta where it acts as a molecular sieve. In this study, we show that P-gp is also expressed in the proliferating cytotrophoblast (CT), the syncytiotrophoblast (ST) and the extravillous trophoblast (EVT), suggesting our hypothesis of a functional role for P-gp in placental development. Silencing of ABCB1, via siRNA duplex, results in dramatically reduced invasion and migration, and increased tube formation and fusion in the EVT-like HTR8/SV neo cell line. In both EVT and CT explant differentiation experiments, silencing of ABCB1 leads to induction of the fusion markers human hCG, ERVW-1 and GJA1 and terminal differentiation of both trophoblast subtypes. Moreover, P-gp protein levels are decreased in both the villous and the EVT of severe early-onset pre-eclamptic placentas. We conclude that, in addition to its role as a syncytial transporter, P-gp is a key factor in the maintenance of both CT and EVT lineages and that its decrease in severe pre-eclampsia may contribute to the syncytial and EVT placental pathologies associated with this disease.
from defective placental development and failure of the placenta to provide gas and nutritional exchanges to support foetal growth. 3, 4 There is no proven treatment or prevention for PE. Low-dose aspirin has been shown to have a protective effect, 5 and blood tests to identify patients at high risk through elevated soluble FMS-like tyrosine kinase-1:placental growth factor ratios are now being used in certain populations with some success. 6 With regard to IUGR, genetic factors have begun to be compiled. 7 While little is known about PE and IUGR aetiology, placental pathology is known to be involved and may play a central role. The initiating cause of PE is thought to be the failure of the placental extravillous trophoblast (EVT) to effectively invade and physiologically transform the uterine spiral arteries, thereby decreasing the volume of maternal blood flow into the intervillous space while increasing blood pressure to a level often incompatible with normal pregnancy. 8 There are several negative consequences of this decreased but high-pressure intervillous blood flow, including oxidative and physiological stress in the villous placenta, disrupted villous trophoblast turnover and increased shedding of necrotic placental debris into the maternal circulation. 9 While the molecular mechanisms underlying this failure are not well understood, an imbalance of trophoblast trophic factors in both PE and IUGR has been well documented. 10 P-glycoprotein (P-gp, encoded by the ABCB1 gene) is a critical component of the placental barrier that may have an important role in supporting the balance of trophic factors. P-gp is an ATP-binding cassette transporter that acts as a molecular sieve in the cytotrophoblasts (CTs) and syncytiotrophoblasts (ST) of the placental barrier. P-gp prevents the entry of many different substrates to the foetal compartment, including maternally transported steroids, toxins and xenobiotics, and may in this way affect trophic factors directly as well as indirectly. 11, 12 P-gp also expressed in the EVT-like first trimester trophoblast cell line HTR8/SVneo, 13 suggesting a role in EVT migration. However, less is known about P-gp function in the CT and EVT. Several lines of evidence suggest that P-gp plays a functional role in the establishment of a healthy and functional syncytium: (a) P-gp is abundantly expressed at the microvillous surface membrane of the ST facing the placental intervillous space and at the apical membrane of the CT facing the syncytium 12 ; (b) proliferation of villous CT, such as during culture in low tension oxygen, is associated with increased expression of P-gp 12 ; and (c) during syncytial differentiation, villous CT normally exit the cell cycle and fuse with the terminally differentiated ST, 14 but when fusion is dysregulated, villous pathology is established leading to PE and/or IUGR. 14, 15 In the anchoring cell column of the early placenta, EVT cells transition from a proliferating phenotype to a transiently invasive phenotype upon penetration into the decidua and myometrium. These transitioning cells are tightly regulated: proliferating EVT is EGFR/ HER1/ITGA5-positive; invasive EVT is HER2/ITGA1-positive. 16, 17 Little is known regarding the differentiation of the EVT invasive phenotype once they are within the decidua during the establishment of the uteroplacental circulation. We do know that invasive EVT penetrate the uterine decidua but go no further than the first third of the myometrium before undergoing a terminal differentiation to become non-invasive. Various types of EVT are observed in the term placental bed including large single cuboidal or polygonal cells, intramural and endovascular trophoblasts and a number of multinuclear trophoblast giant cells (MGC). 18 How the latter population forms is not known, although both cell-cell fusion and endoreduplication of EVT are thought to contribute. 19, 20 That failure to exit the invasive pathway is associated with both placenta accreta and choriocarcinoma 21, 22 underlying the importance of placental molecular and cellular integrity in healthy pregnancy outcome.
Based on the function of P-gp as a molecular sieve, its widespread and abundant expression in CTs and EVTs, and its role in the establishment of a healthy/functional syncytium, we have been suggested that P-gp regulates CT fate and EVT invasion, which are paramount to placental development, uterine spiral artery remodelling and the establishment of normal maternal-foetal circulation. We used human placental tissues, the human HTR8/SV neo cell line and two different human placental explant models to conduct our studies.
The HTR8/SV neo cell line is widely used for first trimester EVT studies and expresses P-gp abundantly, 13 whereas the two ex vivo first trimester placental explant systems model the "EVT pathway" and the "villous pathway". 14, 16 2 | MATERIALS AND METHODS
| Cell line and culture
HTR8/SV neo is a non-tumorigenic, invasive SV40 large T-antigenimmortalized EVT cell line established in 1993. 23 Cells were cultured in RPMI 1640 medium (Thermo Fisher Scientific, Canada) supplemented with 10% foetal bovine serum (FBS; Wisent, Canada) and 0.1% Normocin (InvivoGen, San Diego, USA) in a humidified atmosphere containing 5% CO 2 at 37°C. Cells were confirmed to be free of mycoplasma by PCR. Immunostaining showed that these cells were cytokeratin 8-positive, while immunonegative for the fibroblast-specific marker CD90 ( Figure S1C ).
| Tissue collection
First and second trimester placentas (5-8, 10- Table 1 ). Placental samples used in this study were from the following sources: (a) Term healthy elective caesarean sections (38-41 weeks, n = 9); (b) Preterm placenta both with (n = 4) and without (n = 5) confirmed chorioamnionitis (27-34 weeks, n = 9 total); (c) Severe early-onset PE with either an average for DUNK ET AL. | 5379 gestational age baby (AGA) of 28-34w (n = 9); or with a small for gestational age baby (SGA) of 28-34w (n = 9). Frozen tissue was ground under liquid nitrogen in a mortar and pestle and matched sets of RNA and protein were extracted. All research using human tissues was performed in a class II certified laboratory and in accordance with Health Canada guidelines and regulations. 
| In situ hybridization

| RNA extraction
Total RNA was extracted using TRIzol (Thermo Fisher Scientific), following a slightly modified protocol for improved yield and integrity. 25 RNA pellets were resuspended in Millipore water and temporarily stored at −80°C. RNA was DNase I-treated (1U DNase I per μg of RNA; Thermo Fisher Scientific) and repurified using RNeasy columns (Qiagen). RNA quantity and purity were assessed using NanoDrop ND 1000 spectrophotometry and 1% gel electrophoresis.
| Reverse transcription and real-time SYBR green PCR analysis
RNA samples for subsequent RT-PCR (1 μg) were reverse transcribed using iScript gDNA clear cDNA synthesis kit (Bio-Rad, Mississauga, Ontario, CA). cDNA (~20 ng) was used to amplify the reference genes (YWHAZ and TOP1) or the target genes' (ABCB1, ABCC2, ABCG2, HLA-G, PCNA, GCM1, GJA,1, ERVW-1 and ASCT-2) amplicons using previously optimized or published primers with close to 100% efficiency ( To ensure equal loading, the gel membranes were stripped and reprobed using a rabbit polyclonal antibody to 14,3,3 zeta dilution of 1:2000. We have previously shown that this protein is stably expressed in the human placenta across gestation and in all T A B L E 2 Real-time qPCR SYBR green primer sequences mRNA Primer name Sequence
All primers were blasted using NCBI primer blast to ensure specificity to the gene of interest and confirmed to produce a single band of the expected size by PCR analysis.
pathologies. 26 Band intensity and area were analysed using Quantity One 4.6.7 software (Bio-Rad).
| ABCB1 siRNA duplex knockdown of HTR8/ SV neo cells
Approximately 1.5 × 10 6 HTR8/SV neo cells in log phase of growth were seeded in 100 mm dishes and grown to 50% confluence over 24 hours. The cells were washed and incubated in medium Optimem (Thermo Fisher Scientific) for 1 hours prior to transfection. Experiments to determine the optimal predesigned siRNA (out of 10) iden- siRNA and Lipofectamine RNAiMax (Thermo Fisher Scientific) were first diluted separately in Optimem, then mixed together and incubated at room temperature (RT) for 5 minutes before addition to the cells/placental explants and a 4 hours incubation in a humidified atmosphere containing 5% CO 2 at 37°C. The supernatant was then removed, the cells/explants were rinsed and fresh RPMI 10% FBS was added and incubated for the experimental period.
| Cell growth, viability and fusion of HTR8/ SV neo cells
1.5 × 10 6 HTR8/SV neo cells in log phase of growth were seeded in 100 mm dishes and grown to 30% to 50% confluence over 24 hours. Following transfection with either NC-1 or Dsi2 ABCB1, cells were incubated for a further 24 hours. Cells were counted using the Trypan Blue exclusion method. Cells were first dissociated using Accutase as per the manufacture's protocol (Sigma Aldrich Canada, Oakville, Ontario, Canada). Numbers of viable (clear) and dead (blue) cells were counted using a haemocytometer. In the fusion assays, transfected HTR8/SV neo cells were seeded in 12-well plates at a density of 7 × 10 5 cells/well and cultured for a further 48 hours before fixation in 4% PFA and processing for E-cadherin immunofluorescent staining.
| HTR8/SV neo invasion and migration assays
Invasion assays were performed as previously described 27 
| Placental explant cultures and treatment
Two ex vivo placental explant models were used to investigate whether P-gp is involved in EVT and CT differentiation pathways as follows:
| EVT pathway
EVT explant cultures were established from first trimester human placentas using the method described previously. 16 
| Fluorescent immunohistochemistry
Placental tissues and explants were fixed and processed to paraffin sections (5 μm) on Superfrost Plus glass slides (VWR, Mississauga, Ontario, Canada). Sections were deparaffinized in xylene and rehydrated through a descending concentration gradient of ethanol. Antigen retrieval specific to each antibody was performed as indicated 28 All primary and secondary antibodies used in these procedures are detailed in Table 3 and were used to assess trophoblast differentiation status (EVT markers: HER2, ITGA1;
Syncytial Markers: alpha-hCG, Cx43 (GJA1) and Syncytin 1 (ERVW-1)). In the fusion experiments, treated HTR8/SV neo were stained with a rabbit monoclonal antibody against E-cadherin (Abcam), while in Data availability: The data sets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
| RESULTS
| P-gp/ABCB1 mRNA and protein expression in the villous and extravillous trophoblast
In situ hybridization (ISH) in first trimester placental sections showed high levels of P-gp/ABCB1 mRNA in both the villous CT ( Figure 1A) and the EVT ( Figure 1C ). Sense controls did not show any specific staining ( Figure 1B,D) . Immunohistochemistry using anti-MDR-1 antibody (D11) also showed staining in both the villous CT and EVT in the first trimester ( Figure 1E , arrows), in the interstitial EVT population within the decidua at 18w (Figure 1F , arrows) and at term (Figure 1G, arrows). Syncytial (ST) staining was also observed in the first trimester (E) and at term. Mouse IgG control showed no specific staining ( Figure 1H ). (P = 0.0004; Figure 2A ). Knockdown had no effect on either ABCC2
| Silencing of P-gp/ABCB1 reduces HTR8/SV neo cell proliferation and invasion and induces cell fusion
or ABCG2, two other ATP-binding cassette transporters of the syncytial barrier (P = 0.638 and 0.223, respectively), confirming specificity.
Western blotting, using a rabbit anti-P-gp/ABCB1 antibody previously validated in our laboratory, 29, 30 confirmed reduction in P-gp protein (P = 0.0012; Figure 2B ). Treatment with Dsi2 siABCB1 resulted in a concomitant reduction in the number of viable cells DUNK ET AL. Figure S1A ).
| Silencing of P-gp/ABCB1 drives EVT differentiation, vasculogenic tubule formation and fusion
HTR8/SV neo cells are well known to spontaneously form tubules when plated on Matrigel. 31 Upon treatment with Dsi2 siABCB1, these cells formed large, extensive networks incorporating the majority of the seeded cells within 16 hours of seeding (Figure 3A) . Controls treated with NC-1 or not treated at all only showed the first stages of early tubule formation at the same time-point, with most cells remaining as either distinct entities or as small colonies. Quantitation of total tube length showed a highly significant and robust increase above that of controls going from 1.46 ± 0.5 mm in untreated cells to 5.46 ± 1.4 mm in Dsi2treated cells (P < 0.0001; Figure 3A ), representing nearly a threefold increase.
In the EVT explant model, we observed an unexpected and pre- All antibodies used in the study were optimized for antigen retrieval and dilution. 
| P-gp/ABCB1 expression is decreased in PE placenta
Although one-way ANOVA analysis of the qPCR data from ABCB1 mRNA levels in healthy, preterm and severe PE placentas identified significant variation (P < 0.05), subsequent post hoc tests did not show any significant difference between patient groups (P = 0.0595; Figure 5A ).
Western blotting of term and preterm controls and severe early- Figure 5C ). In the villous CT and ST of PTC placenta, P-gp/ABCB1 staining was consistently strong, whereas, in the PE placentas, which displayed characteristic CT depletion and ST aggregation, P-gp/ABCB1 was weakly expressed in the syncytial cytoplasm (PE, Figure 5C ). In the HLA-G+ EVT of the placental bed, P-gp/ABCB1 was also strong in 
| DISCUSSION
In this study, we have shown that P-gp is expressed at both the mRNA and protein levels in the proliferating CT, in the ST and in the invasive EVT of the first trimester human placenta, as well as in the F I G U R E 3 ABCB1 silencing induces tube formation and fusion markers in primary EVT: A, Representative images of two of three independent tube formation experiments (N1 and N2). HTR8/SV neo cells untreated or transfected with either NC-1 or Dsi2 ABCB1 were seeded in Matrigel-coated plates and incubated overnight. Silencing of ABCB1 induced a robust and rapid formation of an extensive tubular network as compared to either NC-1 or untreated controls. Graph shows total tube length over triplicate images per well (P < 0.0001 vs NC-1 control). B, Established EVT outgrowths (5-7w) were transfected with either NC-1 (top panels) or Dsi2 ABCB1 (lower panels) and cultured for 48 h. Explant morphology shows that silencing of ABCB1 promotes tubule formation in the EVT outgrowth (n = 6). C, Bar graph showing the change in EVT and fusion marker mRNA levels in primary EVT cell columns following 48 h of ABCB1 silencing as determined by qPCR. Fusion markers GJA1 and ERVW-1 were increased on treatment with DSi2 ABCB1 (*P < 0.05 GJA1 only). ABCB1 levels decreased as expected (P < 0.05) as did PCNA and GCM-1 (**P < 0.001, n = 3). Data are expressed as the relative fold change from NC-1 controls at 1.0. Data were normalized as in Figure 2A . Data were analysed using one-way ANOVA and Bonferroni post hoc testing or the paired Student's t test in C. Graphs show the mean and standard deviation. Scale bars = 400 μm DUNK ET AL.
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ST of the term placenta. EVT-specific expression was maintained in invasive interstitial EVT throughout gestation and in differentiated individual cuboidal EVT at term. These data confirm, extend and validate our previous reports of P-gp expression in these trophoblast subtypes. 11, 19, 32 This is important considering that P-gp is a critical component of the placental barrier and hence critical for a healthy pregnancy outcome, through its role in maintaining a balance of trophic factors. Notably, these data also further demonstrate a functional role for P-gp in EVT invasion.
To first investigate this, we utilized the first trimester EVT cell line HTR8/SV neo and studied the effects of silencing ABCB1 expression in proliferation, invasion and fusion assays. We showed that specific and effective silencing of ABCB1 reduces the proliferation rate of HTR8/SV neo cells. Furthermore, we demonstrated for the first time, a role for P-gp in EVT invasion, as silencing of its expression results in the near complete blockade of HTR8/SV neo invasion and migration ( Figure S1B ). Other studies have shown that P-gp is essential for immune cell migration; as either verapamil (a calcium channel blocker and inhibitor of P-gp) or neutralizing antibodies against P-gp have been shown to prevent the migration of both dendritic cells and T cells out of cultured human skin explants. 33 More recently, overexpression of P-gp in breast and oral cancer cell lines | 5389 early implantation site environment and the many differential effects of progesterone, growth factors, chemokines, sphingolipids and cholines on P-gp expression and function. 35 It remains an important question and will be the focus of future studies.
Interestingly, although trophoblast invasion was prevented by ABCB1 silencing, we showed in HTR8/SV neo cells that knockdown of ABCB1 induced markers of fusion such as GJA1 (Cx43), ERVW-1 (Syncytin-1) and hCG and increased the fusion index with aggregates showing features of both endoreduplication and endomitosis. 36 It is known that HTR8/SV neo cells are maintained by a stem cell side population (SP) that expresses a higher level of ABCG2 mRNA than the non-side population (NSP). 37 Moreover, treatment of the SP HTR8/ SV neo with verapamil (a P-gp inhibitor) was similarly shown to result in their terminal differentiation to the NSP subtype. 37 These results collectively support a potential role for P-gp in the maintenance of the trophoblast progenitor population.
HTR8/SV neo cells are also well known to spontaneously form tubes when seeded on Matrigel and express genes that are associated with actin cytoskeleton organization, cell migration and blood vessel development. 31 However, when ABCB1 was silenced, we observed an increase in the speed of tube formation and a large increase in the complexity and in the length of the total tube network formed compared to that observed in controls. More unexpectedly, we observed a similar effect of ABCB1 knockdown on vasculogenesis and syncytialization of primary EVT cells in both explants and microdissected EVT anchoring columns. In ABCB1silenced EVT outgrowths, we reproducibly observed distinct tubes and spikes that, although remaining positive for the EVT marker HLA-G, coexpressed the syncytial fusion markers hCG and Syncytin-1 but lost the invasive EVT markers ITGA1 and the HER2 receptor. 16, 38 We also observed an acceleration in CT fusion to form ST in the floating villous explant model where silencing of ABCB1 resulted in the separation of a double-layered syncytium with the formation of a new syncytium underneath it, within 24 hours. This process usually takes 72 hours in untreated explants which will shed and spontaneously generate a new syncytium in appropriate culture conditions. 14, 39 In both the separated layer and in the new syncytium, Cx43 levels were induced at the junction between CT and SYT, and hCG was increased at the apical side of the new syncytium, indicating acceleration of CT fusion to form ST. The role of P-gp in trophoblast fusion is less surprising as a number of studies have reported the loss or down-regulation of P-gp in the spontaneous differentiation of primary CT to ST. [40] [41] [42] It is also well known that trophoblast fusion stimulated by the protein kinase A pathway and cAMP involves the induction of GJA1 and hCG. 43 Knockdown of their expression in the BeWo choriocarcinoma model results in an arrest of forskolin-stimulated fusion, 44, 45 while overexpression of Cx43 permits Jeg-3 cell fusion. 28 As a point of speculation, beyond its well-known role in substrate distribution and bioavailability and in multidrug resistance, P-gp plays a role in cancer cell invasion, drug resistance and metastasis. [46] [47] [48] [49] For example, proto-oncogene tyrosine-protein kinase SRC-mediated phosphorylation of Annexin A2 (ANXA2) leads to its direct interaction with P-gp and promotes breast cancer cell invasion in vitro. 50 The findings reported here seen from the epithelialmesenchymal transition (EMT) perspective, as they are utilized by both tumour cells and trophoblast cells, raised the intriguing possibility that P-gp can directly regulate EVT differentiation. Our observations may reflect the final or terminal EMT of the IT-EVT phenotype into MGC. In vivo, invasive interstitial HLA-G+ EVT (IT-EVT) within the decidua have been reported to accumulate in clusters preceding their fusion into MGC after 12 weeks of gestation 20 and to express both ERVW-1 and hCG. 51, 52 As stated above, this process is purely speculative, as no actual cell fusion event has been visualized in the placental bed and the alternative pathway of endoreduplication is also suggested to contribute to MGC formation. 53 Collation of the effects of ABCB1 silencing in our EVT models supports the hypothesis of cell-cell fusion in MCG formation but also suggests a joint role with endoreduplication and endomitotic events as seen in the HTR8 fusion assay.
Interestingly, we also observed a significant decrease in P-gp protein levels in severe early-onset PE villous placenta samples as compared to gestational-matched preterm controls (PTC). This decrease was only observed at the protein level suggesting that post-translational regulation of P-gp may be affected as has been reported in MCF-7 doxorubicin-resistant cancer cell lines. 54 In the IHC, the PE placenta displayed an accelerated ST maturation and loss of CT as expected, 55 along with a decrease in P-gp protein, demonstrating diffuse cytoplasmic syncytial and vasculo-syncytial membrane staining and mirroring our observations in the floating explant model. In contrast, the PTC placenta, like the term placenta in Fig. 1 , displays both strong CT and ST vasculo-syncytial membrane staining.
Pregnancies complicated by pre-eclampsia (PE) also display an increase in numbers of MGC in the placental bed greater than that of healthy controls. 18, 56 Al-Nasiry and colleagues have suggested that this increase may be associated with accelerated interstitial IT-EVT fusion as assessed by loss of E-cadherin staining. 57 Interestingly, we found that P-gp expression was also reduced in the IT-EVT in the placental bed of severe early-onset PE placentas as compared to gestational-matched preterm controls. In PE placental beds, EVT was restricted to the peripheral decidua and predominantly accumulated in clusters containing an increased number of MGC that were weakly P-gp-positive. In contrast, in preterm control placental beds, the EVT had invaded far more extensively and lower numbers of fused multinucleate areas with concomitant loss of P-gp were observed. Endoreduplication events cannot be excluded as the nuclei of these cells are also enlarged. P-gp staining was strong in isolated individual EVT in the placenta bed in both preterm controls and PE EVT, again supporting a role for P-gp in maintenance of individual EVT cells. Excessive decidual inflammation during the early events of EVT invasion is a contributory factor in shallow placentation, abruption and PE. 58 These data, together with our previous data showing that preterm placentas with acute chorioamnionitis also show decreased human placental P-gp expression 59 and that acute maternal inflammation leads to decreased placental P-gp activity in a pregnant mouse model, 60 lead us to suggest that aberrant early decidual inflammation may reduce P-gp expression by EVT. This would accelerate EVT terminal differentiation and thus contribute to the failure of EVT-mediated uterovascular transformation associated with the development of PE. 61, 62 Further investigation of the function of P-gp in EVT will enhance our understanding of human placentation and disease and of placental epithelial-mesenchymal transition (EMT) invasion processes in particular. Our data also highlight a need for an investigation of P-gp expression and function in the invasive pathologies of the placenta, such as choriocarcinoma and placenta accreta.
In summary, we have shown for the first time that functional silencing of P-gp results in the terminal differentiation of both CT and EVT along the fusogenic syncytial pathway. These results support a key role for ABCB1 and P-gp in the maintenance of villous and extravillous trophoblast populations of the placenta.
As these pathways of trophoblast turnover and differentiation are compromised in both IUGR and PE placentas, we suggest that P-gp loss or down-regulation may contribute to the development of these placental pathologies. It is important to note that, as P-gp function is affected by a number of prescription drugs and inflammatory events, the implications of a functional role for P-gp in trophoblast cell fate and placental development are of critical importance to a healthy pregnancy. To our knowledge, this is the first study on the functional role of P-gp in the EVT and invasive phenotypes.
